Cummings James F. 4
4 · Vaxart, Inc. · Filed Mar 21, 2023
Insider Transaction Report
Form 4
Vaxart, Inc.VXRT
Cummings James F.
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2023-03-17+205,000→ 205,000 totalExercise: $0.78Exp: 2033-03-16→ Common Stock (205,000 underlying) - Award
Common Stock
2023-03-17+45,000→ 88,750 total - Award
Common Stock
2023-03-17+59,350→ 148,100 total - Award
Common Stock
2023-03-17+90,000→ 238,100 total - Award
Stock Option (right to buy)
2023-03-17+410,000→ 410,000 totalExercise: $0.78Exp: 2033-03-16→ Common Stock (410,000 underlying)
Footnotes (4)
- [F1]Grant of shares upon vesting of restricted stock units, which shall fully vest on December 8, 2023.
- [F2]The shares subject to this stock option shall fully vest on December 8, 2023.
- [F3]Grant of shares upon vesting of restricted stock units. Twenty five percent of the shares underlying the award shall vest on each anniversary of the vesting commencement date of February 2, 2023, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date.
- [F4]The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on February 2, 2024, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on February 2, 2027.